{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-123681","form_type":"8-K","ticker":"FLGT","cik":"0001674930","company_name":"Fulgent Genetics, Inc.","filed_at":"2024-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.190898+00:00","generated_at":"2026-05-30T02:53:14.171568+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Fulgent Q3 core rev $71.7M (+9% YoY), GAAP loss $0.48, non-GAAP EPS $0.31; guides FY core rev $280M","bullets":["Total revenue $71.7M, core revenue (ex-COVID) $71.7M, up 9% YoY.","GAAP net loss $14.6M ($0.48 per share); non-GAAP net income $9.4M ($0.31 per share).","Adjusted EBITDA income $0.4M; cash and marketable securities $815.4M.","Reiterated FY2024 core revenue guidance of $280M; improved EPS guidance for 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-123681","json":"https://secwatch.observer/filing/0000950170-24-123681.json","markdown":"https://secwatch.observer/filing/0000950170-24-123681.md","text":"https://secwatch.observer/filing/0000950170-24-123681.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674930/000095017024123681/0000950170-24-123681-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674930/000095017024123681/flgt-20241108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:53:14.171568+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}